跳至主要内容
临床试验/NCT00529594
NCT00529594已完成不适用

Analgesic Effect of Etoricoxib (ARCOXIA®) 120MG During Retinal Laser Photocoagulation

University of Sao Paulo1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2006年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
44
试验地点
1
主要终点
The group taking the etoricoxib feel less pain then the group taking placebo

研究概览

简要总结

The study wants to show if the medication etoricoxib 120 mg have reduces the patients pain during the laser photocoagulation, for diabetic retinopathy.

详细描述

To do so we compare two group of patients, randomized 1:1, one use the medication(etoricoxib) and other use placebo and they quantify the pain using the Pain visual analogue scale

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
17 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with diabetic retinopathy that needs laser photocoagulation for the first time

排除标准

  • Younger than 17
  • Signs and symptoms of liver dysfunction or abnormal liver function tests
  • Gastrointestinal diseases
  • Pregnant women
  • Pre-existing cardiac insufficiency

研究组 & 干预措施

Control Group

Placebo Comparator

Patients who received placebo

干预措施: placebo (Control Group) (Drug)

Treatment Group

Active Comparator

Patients who received etoricoxib 120 mg

干预措施: Etoricoxib (Treatment Group) (Drug)

结局指标

主要结局

The group taking the etoricoxib feel less pain then the group taking placebo

时间窗: After each laser session

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验